2015年天津市恶性肿瘤流行情况分析

doi:10.11904/j.issn.1002-3070.2020.02.006

摘要/Abstract

摘要： 目的了解天津市居民2015年恶性肿瘤流行情况。方法按地区、性别等分层,分别计算天津市恶性肿瘤发病与死亡粗率、标化率、累积率(0~74岁)及前10位恶性肿瘤发病与死亡顺位和构成等。结果 2015年天津市恶性肿瘤发病率为319.17/10万(男性314.55/10万,女性323.80/10万),中标率181.17/10万,世标率175.15/10万。城市地区恶性肿瘤发病率为383.27/10万,农村为252.50/10万。恶性肿瘤发病前5位分别是肺癌、结直肠癌、乳腺癌、甲状腺癌和肝癌。全市恶性肿瘤死亡率为185.73/10万(男性214.16/10万,女性157.14/10万),中标率92.22/10万,世标率90.78/10万。城市地区恶性肿瘤死亡率为229.02/10万,农村为140.71/10万。恶性肿瘤死亡前5位分别是肺癌、肝癌、结直肠癌、胃癌和胰腺癌。结论天津市恶性肿瘤发病率较全国平均水平低,但女性恶性肿瘤发病率较全国平均水平高,恶性肿瘤死亡率呈现城区高于农村、男性高于女性的特点。

关键词: 恶性肿瘤, 发病率, 死亡率

Abstract: Objective The aim of this study was to understand the epidemic situation of malignant tumors in Tianjin during 2015.Methods According to the stratification by region and gender,the crude incidence,standardization rate,cumulative rate(0~74 years),the incidence and death order and composition of the top 10 malignant tumors in Tianjin were calculated.Results In 2015,the incidence of malignant tumors in Tianjin was 319.17/100,000(314.55/100,000 for males and 323.80/100,000 for females),the bid winning rate was 181.17/100,000,and the world standard trte was 175.15/100,000.The incidence of malignant tumors in urban areas was 383.27/100,000,and in rural areas was 252.50/100,000.The top five cancers were lung cancer,colorectal cancer,breast cancer,thyroid cancer and liver cancer.The city's mortality rate for malignant tumors was 185.73/100,000(214.16/100,000 for males,157.14/100,000 for females),ASRC was 92.22/100,000,and ASRW was 90.78/100,000.The mortality of malignant tumors in urban areas was 229.02/100,000,and that in rural areas was 140.71/100,000.The top five deaths from malignant tumors were lung cancer,liver cancer,colorectal cancer,gastric cancer and pancreatic cancer.Conclusion The incidence of malignant tumors in Tianjin was lower than the national average,but the incidence of malignant tumors in women is higher than the national average.The mortality of malignant tumors is higher in urban areas than in rural areas,and higher in men than in women.

Key words: Cancer, Incidence, Mortality

中图分类号:

孙坤, 王冲, 沈成凤, 张爽, 张辉, 宋桂德, 王卓, 王德征. 2015年天津市恶性肿瘤流行情况分析[J]. 实用肿瘤学杂志, 2020, 34(2): 114-119.

SUN Kun, WANG Chong, SHEN Chengfeng, ZHANG Shuang, ZHANG Hui, SONG Guide, WANG Zhuo, WANG Dezheng. Prevalent analysis of malignant tumors in Tianjin,2015[J]. Journal of Practical Oncology, 2020, 34(2): 114-119.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.02.006

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I2/114

参考文献

1 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016,59-75.
2 Bray F,Parkin DM.Evaluation of data quality in the cancer registry:principles and methods.Part I:comparability,validity and timeliness[J].Eur J Cancer,2009,45(5):747-55.
3 Parkin DM,Bray F.Evaluation of data quality in the cancer registry:principles and methods Part II.Completeness[J].Eur J Cancer,2009,45(5):756-764.
4 Curado MP,Edwards B,Shin HR,et al.Cancer incidence in five continents,Vol.Ⅺ[M].Lyon:IARC,2008.
5 Bray F,Guilloux A,Sankila R,et al.Practical implications of imposing a new world standard population[J].Cancer Causes Control,2002,13(2):175-182.
6 沈成凤,王德征,张爽,等.2010-2012年天津市恶性肿瘤发病分析[J].中国肿瘤,2017,26(1):18-24.
7 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
8 徐忠良,张辉,王德征,等.2015年天津市户籍居民恶性肿瘤死亡及去死因期望寿命分析[J].中华流行病学杂志,2017,38(2):231-234.
9 Chen X,Zhang LW,Huang JJ,et al.Long-term exposure to urban air pollution and lung cancer mortality:a 12-year cohort study in Northern China[J].Sci Total Environ,2016,571:855-861.
10 Guo Y,Zeng H,Zheng R,et al.The association between lung cancer incidence and ambient air pollution in China:A spatiotemporal analysis[J].Environ Res,2016,144(Pt A):60-65.
11 Vineis P,Hoek G,Krzyzanowski M,et al.Air pollution and risk of lung cancer in a prospective study in Europe[J].Int J Cancer,2006,119(1):169-174.
12 Guan WJ,Zheng XY,Chung KF,et al.Impact of air pollution on the burden of chronic respiratory diseases in China:time for urgent action[J].The Lancet,2016,388(10054):1939-1951.
13 Doll R,Peto R.Mortality in relation to smoking:20 years' observations on male British doctors[J].Br Med J,1976,2(6051):1525-1536.
14 Chen ZM,Peto R,Iona A,et al.Emerging tobacco-related cancer risks in China:A nationwide,prospective study of 0.5 million adults[J].Cancer,2015,(Suppl 17):3097-3106.
15 Chen Z,Peto R,Zhou M,et al.Contrasting male and female trends in tobacco-attributed mortality in China:evidence from successive nationwide prospective cohort studies[J].The Lancet,2015,386(10002):1447-1456.
16 Barnoya J,Glantz S.Association of the California tobacco control program with declines in lung cancer incidence[J].Cancer Causes Control,2004,15(7):689-695.
17 Jemal A,Thun MJ,Ries LA,et al.Annual report to the nation on the status of cancer,1975-2005,featuring trends in lung cancer,tobacco use,and tobacco control[J].J Natl Cancer Inst,2008,100(23):1672-1694.
18 Islami F,Chen W,Yu XQ,et al.Cancer deaths and cases attributable to lifestyle factors and infections in China,2013[J].Ann Oncol,2017,28(10):2567-2574.
19 王德征,张爽,张辉,等.天津市结直肠癌死亡率1999-2015年变化趋势分析[J].中华胃肠外科杂志,2019,22(6):579-586.
20 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
21 Fan L,Zheng Y,Yu KD,et al.Breast cancer in a transitional society over 18 years:trends and present status in Shanghai,China[J].Breast Cancer Res Treat,2009,117(2):409-416.
22 Buell P.Changing incidence of breast cancer in Japanese-American women[J].J Natl Cancer Inst,1973,51(5):1479-1483.
23 郑文龙,张爽,沈成凤,等.天津市2010~2014年甲状腺癌流行特征及长期发病和死亡趋势分[J].中国肿瘤,2018,27(9):670-674.

[1]	林玉华, 倪振华, 孙亦鹏, 毕俊杰, 王雄彪. SPDEF与恶性肿瘤关系的研究进展[J]. 实用肿瘤学杂志, 2020, 34(2): 185-188.
[2]	周家琛, 郑荣寿, 庄贵华, 张思维, 曾红梅, 陈茹, 王少明, 孙可欣, 邹小农, 魏文强, 赫捷. 2000—2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J]. 实用肿瘤学杂志, 2020, 34(1): 1-5.
[3]	戴丹, 贾尚春, 陈叶纪, 贺琴, 查震球, 刘志荣. 安徽省肿瘤登记地区2015年胃癌发病与死亡[J]. 实用肿瘤学杂志, 2020, 34(1): 6-10.
[4]	包乐, 唐丽萍. EphB6受体在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 83-87.
[5]	李亚飞, 张霄, 王雪飞, 翁明娇, 王天真. RNA结合蛋白Lin28在恶性肿瘤发生发展中的作用和分子机制[J]. 实用肿瘤学杂志, 2019, 33(5): 456-460.
[6]	陈宏博, 余增荣, 丁小凡肖林. 盆腔肿瘤IMRT下骨髓剂量-体积参数与急性血液学毒性相关性研究进展[J]. 实用肿瘤学杂志, 2019, 33(4): 361-366.
[7]	赵金璐, 李国东刘明. 长链非编码RNA CCAT1与消化系统恶性肿瘤关系的研究进展[J]. 实用肿瘤学杂志, 2019, 33(4): 367-370.
[8]	张茂祥,孙惠昕,宋冰冰. 2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2019, 33(3): 261-265.
[9]	李诚, 兰莉, 杨超, 张婷婷, 王蕊, 林琳, 田文静. 2015—2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J]. 实用肿瘤学杂志, 2019, 33(1): 62-66.
[10]	朱晓云, 张亚宁, 林菲, 马碧萍. 上海市金山区2002-2013年肺癌发病及死亡分析[J]. 实用肿瘤学杂志, 2018, 32(5): 437-441.
[11]	韩滕综述, 唐丽萍审校. PD-L1的表达与妇科恶性肿瘤预后关系的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 468-470.
[12]	韩帮岭, 汪亦民, 薛英威. 中性粒细胞与恶性肿瘤关系的研究进展[J]. 实用肿瘤学杂志, 2018, 32(4): 349-352.
[13]	周洁, 陈钰(综述), 陈道桢(审校). 纳米材料在肿瘤光动力治疗中的应用[J]. 实用肿瘤学杂志, 2018, 32(3): 245-249.
[14]	侯思宇(综述), 陈秀玮(审校). JMJD2B蛋白结构功能及在恶性肿瘤发生发展中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 250-253.
[15]	张婷, 侯光营, 王鑫(综述), 贺岩(审校). QKI蛋白在恶性肿瘤中的研究进展及临床意义[J]. 实用肿瘤学杂志, 2018, 32(3): 263-266.